"Digital Spending by Life Sciences Marketers to Grow Tto $14.25 BN by 2018": 2nd Edition of Path-Breaking The Digital Savvy Pharma Marketer, 2016 Study
ISELIN, N.J., Nov. 21, 2016 /PRNewswire/ -- Indegene (www.indegene.com), a global healthcare solutions provider, today announced the release of its second edition of The Digital Savvy Pharma Marketer, 2016 – a comprehensive global study comprising over 100 senior commercial operations professional across top 40 lifesciences companies in the US, EU, APAC, and China.
Photo - http://photos.prnewswire.com/prnh/20161118/441115-INFO
Digital spending for customer engagement continues to grow globally. In 2016, global marketers have been found to spend an average of 14.85% of their marketing budget on non-personal digital channels, which is expected to grow to 19% by 2018 as revealed in the study. Sanjay Virmani, EVP Indegene, stated that "China and the USA are leading in non-personal digital spending at 33% and 31%, respectively, spending over 20% annually. By 2018, 50% of marketers in China and 40% of marketers in the USA will spend more than 20%."
According to the study, Brand Promotional Emails, KOL Webinars, and HCP Portals are the top three preferred channels by the global marketers to engage HCPs. However, by 2018, KOL Webinars, Social Media, and Mobile Apps are expected to become the most preferred channels of engagement. "We expect to see a slight shift in prioritization of spending, with KOL Webinars becoming the first choice of engagement and Social Media and Mobile Apps receiving greater focus," added Virmani.
The study was conducted by Pharma Future (www.pharmafuture.org), Indegene's independent thought leadership initiative that works closely with some of the most influential thinkers in the life sciences industry. For more information about Pharma Future, please visit www.pharmafuture.org.
A complimentary copy of the study has been made available for a limited period, and can be downloaded here.
Indegene enables global healthcare organizations to address complex challenges by seamlessly integrating analytics, technology, operations, and medical expertise and drive better health and business outcomes. Indegene's IP-based solutions help clients drive revenues and productivity by making transformational leaps in digitalization of customer engagement, health reform, healthcare cost reduction, and health outcomes improvement.
For more information:
Urvi Mehta+91 98863 email@example.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/digital-spending-by-life-sciences-marketers-to-grow-tto-1425-bn-by-2018-2nd-edition-of-path-breaking-the-digital-savvy-pharma-marketer-2016-study-300366072.html